Award details

Increasing the amount of transgene generated translatable mRNA

ReferenceG07302
Principal Investigator / Supervisor Professor Christopher Whitelaw
Co-Investigators /
Co-Supervisors
Institution The Roslin Institute
DepartmentGene Expression and Development
Funding typeResearch
Value (£) 162,258
StatusCompleted
TypeResearch Grant
Start date 01/04/1997
End date 01/04/2000
Duration36 months

Abstract

The objective of this proposal is to generate improved hybrid-constructs capable of targeting high-level protein production to mammary cells. This will be achieved by incorporating RNA sequence elements from hepatitis B virus S gene, herpes simplex virus thymidine kinase gene and the bovine preprolactin gene into constructs encoding either human alpha-1- antitrypsin or factor IX. Mammary specificity will be directed by ovine beta-lactoglobulin sequences. The expression potential of genomic- and cDNA-based modified constructs will be evaluated by comparison to the parental constructs. A comparison of their ability to enhance protein production by stable transfection of cultured cell lines in vitro and in transgenic mice in vivo will enable a rationale design of future expression vectors which will be broadly applicable in all aspects of gene transfer technology.

Summary

unavailable
Committee Closed Committee - Genes & Developmental Biology (GDB)
Research TopicsX – not assigned to a current Research Topic
Research PriorityX – Research Priority information not available
Research Initiative X - not in an Initiative
Funding SchemeX – not Funded via a specific Funding Scheme
terms and conditions of use (opens in new window)
export PDF file